Question 1
Stage C HF is defined as ...
Correct Answer:
Structural heart disease with HF symptoms
Explanation:
The concept being tested is how the ACC/AHA stages of heart failure are defined. Stage C is characterized by structural heart disease with current or prior HF symptoms, meaning you have clear signs or symptoms of heart failure while there is an underlying heart abnormality. Structural heart disease can include previous myocardial infarction with remodeling, valve disease, cardiomyopathy, or other conditions that alter heart structure. The symptoms that accompany it are the typical HF manifestations—shortness of breath, fatigue, reduced exercise tolerance, and sometimes edema. Why the other descriptions don’t fit Stage C: having no symptoms despite reduced left ventricular ejection fraction places you in Stage B (structural disease without symptoms). Refractory HF at rest describes a very advanced stage, i.e., Stage D, where symptoms persist despite optimal therapy. Being at risk but asymptomatic corresponds to Stage A, where there’s risk but no structural heart disease or symptoms yet. So, Stage C = structural heart disease with HF symptoms.
Question 2
What is the role of sacubitril/valsartan in HFrEF and what trial supports it?
Correct Answer:
An ARNI with mortality benefit; PARADIGM-HF showed superiority over enalapril.
Explanation:
Sacubitril/valsartan is an ARNI, combining neprilysin inhibition with angiotensin receptor blockade. Neprilysin inhibition raises natriuretic peptides, producing vasodilation, natriuresis, and anti-remodeling effects, while the valsartan component blocks angiotensin II’s harmful actions. Together, this improves outcomes in HFrEF beyond what ACE inhibitors alone provide. This benefit was shown in the PARADIGM-HF trial, which compared sacubitril/valsartan with enalapril in about 8,400 patients with symptomatic heart failure and reduced ejection fraction. It demonstrated a relative reduction around 20% in the primary outcome of cardiovascular death or heart failure hospitalization, and also lowered all-cause mortality, establishing superiority over an ACE inhibitor. Because of this, guidelines endorse using sacubitril/valsartan in eligible patients to improve outcomes, with a required washout period when switching from an ACE inhibitor to minimize angioedema risk.
Question 3
BiVAD refers to a device providing mechanical support for which parts of the heart?
Correct Answer:
Both ventricles
Explanation:
BiVAD means a biventricular assist device, which provides mechanical support for both ventricles. In advanced heart failure, either or both ventricles may not pump effectively. An LVAD helps the left ventricle move blood into the aorta, while an RVAD helps the right ventricle push blood into the pulmonary artery. A BiVAD uses two pumps to assist both sides, improving overall cardiac output by supporting circulation to both the systemic and pulmonary circuits. Supporting only one ventricle or the atria isn’t what BiVAD is designed to do, so the best choice is the device that aids both the left and right ventricles.
Question 4
In decompensated heart failure, hyponatremia is associated with what prognosis?
Correct Answer:
Poor prognosis
Explanation:
Hyponatremia in decompensated heart failure reflects severe neurohormonal activation and significant fluid overload. When the heart fails to pump effectively, the body senses lowered effective arterial blood volume, which stimulates pathways like antidiuretic hormone release and the renin-angiotensin-aldosterone system. This leads to increased water retention relative to sodium, causing dilutional hyponatremia. This finding correlates with more advanced disease and is a strong marker of worse outcomes, including higher mortality and more frequent hospital readmissions. It signals a prognosis that is poor rather than favorable or neutral, and it does not indicate imminent recovery.
Question 5
Which statement describes guideline-directed medical therapy for HFrEF?
Correct Answer:
It includes RAAS inhibitors, MRAs, beta blockers, and SGLT2 inhibitors
Explanation:
Guideline-directed medical therapy for HFrEF centers on reducing mortality and hospitalizations by using four key drug classes: RAAS inhibitors (ACE inhibitors or ARBs or ARNIs), beta-blockers, mineralocorticoid receptor antagonists, and SGLT2 inhibitors. These classes have strong trial evidence showing survival benefits and fewer hospitalizations, and SGLT2 inhibitors are now recommended as part of standard therapy even in patients without diabetes. Diuretics help with symptoms of fluid overload but do not improve survival, so they are not considered the foundational GDMT. Nitrates with hydralazine can be beneficial in select patients but are not first-line for GDMT in the general HFrEF population.
Question 1
Exam overview

About this Exam

Prepare with the Congestive Heart Failure (CHF) Practice Test practice quiz. This question bank includes 10 questions covering heart, hfref, failure, role, and sacubitril. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

More details

Additional Information

Congestive Heart Failure (CHF) Practice Test

This practice set contains 10 questions from the matching question bank and focuses on heart, hfref, failure, role, and sacubitril. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions